Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

To observe the effect of different antithrombotic drugs on the prognosis of ischemic stroke patients with cerebral microbleeds. And further combined with proteomic methods to explore serological markers that can be used to accurately predict the prognosis of such patients.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Patients diagnosed clinically as ischemic stroke; 2. Age ≥ 40 years; 3. Onset time ≤ 3 months; 4. willing to sign a consent form was signed. Who Should NOT Join This Trial: 1. Patients with symptomatic intracranial hemorrhage; 2. bleeding lesion \> 10 mm was found on SWI; 3. Vascular malformations, tumors, abscesses or other major non ischemic brain diseases were present; 4. There are contraindications for antithrombotic drugs use; 5. Serious systemic diseases; 6. Refusal to sign willing to sign a consent form or poor compliance. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Patients diagnosed clinically as ischemic stroke; 2. Age ≥ 40 years; 3. Onset time ≤ 3 months; 4. Informed consent was signed. Exclusion Criteria: 1. Patients with symptomatic intracranial hemorrhage; 2. bleeding lesion \> 10 mm was found on SWI; 3. Vascular malformations, tumors, abscesses or other major non ischemic brain diseases were present; 4. There are contraindications for antithrombotic drugs use; 5. Serious systemic diseases; 6. Refusal to sign informed consent or poor compliance.

Treatments Being Tested

DRUG

Antithrombotic drugs

The purpose of our study is to observe the effect of various antithrombotic drugs on the prognosis of ischemic stroke patients with cerebral microbleeds.

Locations (16)

Ankang Central Hospital
Ankang, Shaanxi, China
3201 Hospital
Hanzhong, Shaanxi, China
Department of Neurology, Xijing Hospital, Fourth Military Medical University
Xi'an, Shaanxi, China
Yan'an University Affiliated Hospital
Ya'an, Shaanxi, China
Yulin No.2 Hospital
Yunlin, Shaanxi, China
Xi'AN GAOXIN Hospital
Xi'an, Shannxi, China
Hanzhong People's Hospital
Hanzhong, China
986 Hospital
Xi'an, China
Gaoling District Hospital
Xi'an, China
Gem Flower Xi'an Changqing Staff Hospital
Xi'an, China
Tangdu Hospital
Xi'an, China
The First Affiliated Hospital of Xi'an Medical University
Xi'an, China
No.215 Hospital of Shaanxi nuclear industry
Xianyang, China
The First People's Hospital of Xianyang
Xianyang, China
Xian Yang Central Hospital
Xianyang, China
Yan'an People's Hospital
Yan’an, China